| 0 |
ADMINISTRATION SITE PALLOR |
1 |
0.3333 |
| 1 |
NEONATAL HYPERGLYCAEMIA |
10 |
0.2703 |
| 2 |
TRANSCRANIAL ELECTRICAL MOTOR EVOKED POTENTIAL MONITORING ABNORMAL |
7 |
0.2121 |
| 3 |
REEXPANSION PULMONARY OEDEMA |
2 |
0.1667 |
| 4 |
NASOGASTRIC OUTPUT HIGH |
2 |
0.1667 |
| 5 |
PHRENIC NERVE INJURY |
3 |
0.1500 |
| 6 |
HEART RATE VARIABILITY DECREASED |
4 |
0.0976 |
| 7 |
PARATONIA |
2 |
0.0769 |
| 8 |
CANNABIS INTERACTION |
1 |
0.0769 |
| 9 |
LUNG ASSIST DEVICE THERAPY |
4 |
0.0645 |
| 10 |
TRIGEMINO-CARDIAC REFLEX |
5 |
0.0617 |
| 11 |
INFANT IRRITABILITY |
6 |
0.0612 |
| 12 |
ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST |
1 |
0.0588 |
| 13 |
BURKHOLDERIA TEST POSITIVE |
7 |
0.0565 |
| 14 |
GLOSSOPTOSIS |
12 |
0.0548 |
| 15 |
BEZOLD-JARISCH REFLEX |
2 |
0.0526 |
| 16 |
HYPOCAPNIA |
22 |
0.0526 |
| 17 |
MYOCARDIAL CALCIFICATION |
6 |
0.0513 |
| 18 |
NEGATIVE PRESSURE PULMONARY OEDEMA |
4 |
0.0408 |
| 19 |
FLOPPY IRIS SYNDROME |
15 |
0.0408 |
| 20 |
IMMUNODEFICIENCY CONGENITAL |
1 |
0.0400 |
| 21 |
ELECTROCARDIOGRAM R ON T PHENOMENON |
2 |
0.0400 |
| 22 |
BASELINE FOETAL HEART RATE VARIABILITY DISORDER |
2 |
0.0364 |
| 23 |
HYPERCAPNIC COMA |
5 |
0.0352 |
| 24 |
UPPER AIRWAY OBSTRUCTION |
29 |
0.0327 |
| 25 |
NEONATAL DYSPNOEA |
3 |
0.0316 |
| 26 |
POSTRESUSCITATION ENCEPHALOPATHY |
2 |
0.0312 |
| 27 |
POSTOPERATIVE DELIRIUM |
6 |
0.0303 |
| 28 |
MECHANICAL VENTILATION COMPLICATION |
4 |
0.0268 |
| 29 |
PAROXYSMAL SYMPATHETIC HYPERACTIVITY |
2 |
0.0267 |
| 30 |
CATHETER SITE NECROSIS |
1 |
0.0263 |
| 31 |
RENAL ISCHAEMIA |
14 |
0.0256 |
| 32 |
PHAEOCHROMOCYTOMA CRISIS |
5 |
0.0236 |
| 33 |
DIABETES INSIPIDUS |
55 |
0.0228 |
| 34 |
FOETAL MEGACYSTIS |
1 |
0.0227 |
| 35 |
SUBCAPSULAR SPLENIC HAEMATOMA |
1 |
0.0222 |
| 36 |
PAROXYSMAL ATRIOVENTRICULAR BLOCK |
1 |
0.0217 |
| 37 |
PUERPERAL PYREXIA |
1 |
0.0200 |
| 38 |
WITHDRAWAL HYPERTENSION |
4 |
0.0198 |
| 39 |
ACUTE MOTOR AXONAL NEUROPATHY |
2 |
0.0192 |
| 40 |
NEONATAL HYPOTENSION |
7 |
0.0190 |
| 41 |
ACQUIRED FACTOR V DEFICIENCY |
2 |
0.0182 |
| 42 |
NEONATAL RESPIRATORY DEPRESSION |
6 |
0.0181 |
| 43 |
ELECTROCARDIOGRAM T WAVE BIPHASIC |
1 |
0.0179 |
| 44 |
SEDATIVE THERAPY |
1 |
0.0175 |
| 45 |
VENTRICULAR ASYSTOLE |
3 |
0.0172 |
| 46 |
IRREGULAR BREATHING |
10 |
0.0170 |
| 47 |
SINUS ARREST |
26 |
0.0166 |
| 48 |
INTESTINAL PSEUDO-OBSTRUCTION |
14 |
0.0159 |
| 49 |
AGITATION POSTOPERATIVE |
1 |
0.0159 |
| 50 |
AIRWAY COMPLICATION OF ANAESTHESIA |
4 |
0.0152 |
| 51 |
HYPOTENSIVE TRANSFUSION REACTION |
1 |
0.0152 |
| 52 |
HAPTOGLOBIN INCREASED |
2 |
0.0146 |
| 53 |
CARDIAC ARREST NEONATAL |
2 |
0.0145 |
| 54 |
PROCALCITONIN DECREASED |
1 |
0.0143 |
| 55 |
SEIZURE LIKE PHENOMENA |
22 |
0.0129 |
| 56 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
78 |
0.0128 |
| 57 |
DIFFUSE LARGE B-CELL LYMPHOMA STAGE III |
1 |
0.0127 |
| 58 |
HEART ALTERNATION |
1 |
0.0125 |
| 59 |
FACTOR V DEFICIENCY |
2 |
0.0125 |
| 60 |
ARTERIOSPASM CORONARY |
50 |
0.0125 |
| 61 |
BACTERIAL TRACHEITIS |
1 |
0.0123 |
| 62 |
RHYTHM IDIOVENTRICULAR |
4 |
0.0123 |
| 63 |
NEONATAL CHOLESTASIS |
1 |
0.0119 |
| 64 |
MEAN ARTERIAL PRESSURE DECREASED |
3 |
0.0119 |
| 65 |
DELAYED RECOVERY FROM ANAESTHESIA |
11 |
0.0116 |
| 66 |
EYELID EROSION |
1 |
0.0115 |
| 67 |
ACQUIRED MACROGLOSSIA |
1 |
0.0112 |
| 68 |
DRUG WITHDRAWAL CONVULSIONS |
20 |
0.0112 |
| 69 |
INFANTILE APNOEA |
9 |
0.0110 |
| 70 |
SEDATION COMPLICATION |
28 |
0.0110 |
| 71 |
EXAGGERATED STARTLE RESPONSE |
2 |
0.0109 |
| 72 |
PRODUCT APPEARANCE CONFUSION |
10 |
0.0108 |
| 73 |
NEONATAL ANURIA |
1 |
0.0105 |
| 74 |
COMPUTERISED TOMOGRAM HEAD ABNORMAL |
1 |
0.0101 |
| 75 |
HYPERTHERMIA MALIGNANT |
15 |
0.0101 |
| 76 |
CARDIAC CIRRHOSIS |
1 |
0.0097 |
| 77 |
CENTRAL SLEEP APNOEA SYNDROME |
3 |
0.0092 |
| 78 |
REFRACTORINESS TO PLATELET TRANSFUSION |
1 |
0.0092 |
| 79 |
PHRENIC NERVE PARALYSIS |
2 |
0.0091 |
| 80 |
PERONEAL NERVE INJURY |
1 |
0.0088 |
| 81 |
DRUG HALF-LIFE INCREASED |
1 |
0.0088 |
| 82 |
ACQUIRED DIAPHRAGMATIC EVENTRATION |
3 |
0.0085 |
| 83 |
CEREBROVASCULAR INSUFFICIENCY |
2 |
0.0083 |
| 84 |
NASAL CAVITY MASS |
1 |
0.0082 |
| 85 |
CALCIFICATION OF MUSCLE |
1 |
0.0080 |
| 86 |
BRADYARRHYTHMIA |
13 |
0.0079 |
| 87 |
INTENSIVE CARE UNIT ACQUIRED WEAKNESS |
3 |
0.0079 |
| 88 |
INTENTIONAL PRODUCT MISUSE TO CHILD |
1 |
0.0078 |
| 89 |
OXYGEN SATURATION |
2 |
0.0076 |
| 90 |
SUBARACHNOID HAEMATOMA |
1 |
0.0075 |
| 91 |
GASTROINTESTINAL MUCOSAL EXFOLIATION |
1 |
0.0075 |
| 92 |
COLONIC PSEUDO-OBSTRUCTION |
2 |
0.0072 |
| 93 |
CSF CELL COUNT INCREASED |
1 |
0.0068 |
| 94 |
FIBRIN DEGRADATION PRODUCTS INCREASED |
2 |
0.0068 |
| 95 |
SPECIFIC GRAVITY URINE DECREASED |
1 |
0.0065 |
| 96 |
NEUROLOGICAL EXAMINATION ABNORMAL |
3 |
0.0064 |
| 97 |
ECHOLALIA |
2 |
0.0063 |
| 98 |
NEPHROANGIOSCLEROSIS |
1 |
0.0062 |
| 99 |
CONFUSIONAL AROUSAL |
1 |
0.0062 |
| 100 |
HEPATIC CALCIFICATION |
1 |
0.0061 |
| 101 |
PRINZMETAL ANGINA |
6 |
0.0060 |
| 102 |
SCROTAL ERYTHEMA |
1 |
0.0060 |
| 103 |
NERVE CONDUCTION STUDIES ABNORMAL |
1 |
0.0060 |
| 104 |
HYPORESPONSIVE TO STIMULI |
7 |
0.0060 |
| 105 |
PRODUCT CLOSURE REMOVAL DIFFICULT |
6 |
0.0059 |
| 106 |
ACUTE RIGHT VENTRICULAR FAILURE |
1 |
0.0059 |
| 107 |
RECURRENCE OF NEUROMUSCULAR BLOCKADE |
1 |
0.0058 |
| 108 |
PNEUMOPERICARDIUM |
1 |
0.0058 |
| 109 |
HAEMOCONCENTRATION |
1 |
0.0058 |
| 110 |
PROPOFOL INFUSION SYNDROME |
4 |
0.0057 |
| 111 |
CARDIAC OUTPUT DECREASED |
5 |
0.0057 |
| 112 |
DRUG-GENETIC INTERACTION |
2 |
0.0056 |
| 113 |
ORAL DISCHARGE |
2 |
0.0055 |
| 114 |
WEANING FAILURE |
2 |
0.0055 |
| 115 |
LARYNGEAL OBSTRUCTION |
1 |
0.0055 |
| 116 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
16 |
0.0053 |
| 117 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
37 |
0.0052 |
| 118 |
ATONIC URINARY BLADDER |
1 |
0.0052 |
| 119 |
ALCOHOLIC PANCREATITIS |
1 |
0.0051 |
| 120 |
SINOATRIAL BLOCK |
3 |
0.0050 |
| 121 |
CATHETER SITE EXTRAVASATION |
2 |
0.0050 |
| 122 |
SHIFT TO THE LEFT |
1 |
0.0049 |
| 123 |
NEONATAL HYPOXIA |
4 |
0.0048 |
| 124 |
LARYNGOSPASM |
13 |
0.0048 |
| 125 |
PRODUCT ADMINISTRATION ISSUE |
1 |
0.0048 |
| 126 |
ELECTROCARDIOGRAM PR SHORTENED |
1 |
0.0048 |
| 127 |
REBOUND PSYCHOSIS |
1 |
0.0047 |
| 128 |
ATRIOVENTRICULAR DISSOCIATION |
1 |
0.0047 |
| 129 |
MOYAMOYA DISEASE |
1 |
0.0046 |
| 130 |
TORSADE DE POINTES |
36 |
0.0046 |
| 131 |
RIGHT-TO-LEFT CARDIAC SHUNT |
1 |
0.0045 |
| 132 |
ACUTE LEFT VENTRICULAR FAILURE |
3 |
0.0045 |
| 133 |
RESPIRATORY FATIGUE |
1 |
0.0043 |
| 134 |
VIRAL HAEMORRHAGIC CYSTITIS |
3 |
0.0042 |
| 135 |
ELECTROENCEPHALOGRAM ABNORMAL |
13 |
0.0041 |
| 136 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
6 |
0.0041 |
| 137 |
NODAL RHYTHM |
6 |
0.0041 |
| 138 |
ELECTROCARDIOGRAM P WAVE ABNORMAL |
1 |
0.0041 |
| 139 |
HYPERCALCIURIA |
2 |
0.0041 |
| 140 |
ENTEROBACTER TEST POSITIVE |
1 |
0.0041 |
| 141 |
MATERNAL EXPOSURE DURING DELIVERY |
4 |
0.0040 |
| 142 |
NEONATAL SEIZURE |
1 |
0.0040 |
| 143 |
METASTASES TO SOFT TISSUE |
1 |
0.0039 |
| 144 |
ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY |
3 |
0.0038 |
| 145 |
CULTURE WOUND POSITIVE |
1 |
0.0038 |
| 146 |
HYPOTONIA NEONATAL |
6 |
0.0038 |
| 147 |
HERPES ZOSTER REACTIVATION |
1 |
0.0038 |
| 148 |
RESPIRATORY ACIDOSIS |
15 |
0.0038 |
| 149 |
HYPERTHERMIA |
29 |
0.0038 |
| 150 |
APNOEA |
29 |
0.0037 |
| 151 |
PANCREATIC STEATOSIS |
1 |
0.0037 |
| 152 |
CENTRAL NERVOUS SYSTEM NECROSIS |
1 |
0.0036 |
| 153 |
BLOOD LACTIC ACID INCREASED |
19 |
0.0036 |
| 154 |
ATRIOVENTRICULAR BLOCK COMPLETE |
24 |
0.0036 |
| 155 |
BRADYCARDIA |
190 |
0.0036 |
| 156 |
POSTOPERATIVE FEVER |
1 |
0.0036 |
| 157 |
AGONAL RESPIRATION |
1 |
0.0035 |
| 158 |
NODAL ARRHYTHMIA |
3 |
0.0035 |
| 159 |
VASOCONSTRICTION |
3 |
0.0034 |
| 160 |
ABDOMINAL MASS |
9 |
0.0034 |
| 161 |
ANAESTHETIC COMPLICATION NEUROLOGICAL |
3 |
0.0033 |
| 162 |
RESPIRATORY DEPRESSION |
40 |
0.0033 |
| 163 |
HEPATIC ISCHAEMIA |
1 |
0.0032 |
| 164 |
INCREASED DOSE ADMINISTERED |
1 |
0.0032 |
| 165 |
SINUS BRADYCARDIA |
31 |
0.0032 |
| 166 |
NEONATAL RESPIRATORY DISTRESS |
3 |
0.0032 |
| 167 |
DEVICE PROGRAMMING ERROR |
1 |
0.0032 |
| 168 |
BLADDER INJURY |
1 |
0.0031 |
| 169 |
METABOLIC ALKALOSIS |
5 |
0.0031 |
| 170 |
HYPERPYREXIA |
13 |
0.0031 |
| 171 |
DIABETIC HYPERGLYCAEMIC COMA |
1 |
0.0031 |
| 172 |
BLOOD CREATINE PHOSPHOKINASE DECREASED |
1 |
0.0030 |
| 173 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
10 |
0.0030 |
| 174 |
BLOOD LACTATE DEHYDROGENASE DECREASED |
1 |
0.0030 |
| 175 |
LARYNGOMALACIA |
1 |
0.0030 |
| 176 |
WRONG PRODUCT ADMINISTERED |
20 |
0.0030 |
| 177 |
FOETAL EXPOSURE DURING DELIVERY |
2 |
0.0029 |
| 178 |
PRODUCT PACKAGING CONFUSION |
7 |
0.0029 |
| 179 |
SJS-TEN OVERLAP |
2 |
0.0028 |
| 180 |
HYPERNATRAEMIA |
14 |
0.0028 |
| 181 |
CEREBRAL ARTERY OCCLUSION |
3 |
0.0028 |
| 182 |
LIVIDITY |
1 |
0.0027 |
| 183 |
RESPIRATORY GAS EXCHANGE DISORDER |
1 |
0.0027 |
| 184 |
THYROTOXIC CRISIS |
3 |
0.0026 |
| 185 |
TRACHEITIS |
2 |
0.0026 |
| 186 |
ELECTROCARDIOGRAM PR PROLONGATION |
2 |
0.0026 |
| 187 |
BREATH HOLDING |
1 |
0.0026 |
| 188 |
NEPHROGENIC DIABETES INSIPIDUS |
3 |
0.0026 |
| 189 |
PRODUCT CONFUSION |
2 |
0.0025 |
| 190 |
ELECTROMECHANICAL DISSOCIATION |
2 |
0.0025 |
| 191 |
LONG QT SYNDROME |
6 |
0.0025 |
| 192 |
LYMPHOCYTE STIMULATION TEST POSITIVE |
2 |
0.0025 |
| 193 |
LYMPHOCYTE PERCENTAGE INCREASED |
1 |
0.0025 |
| 194 |
ELECTROCARDIOGRAM ST SEGMENT ABNORMAL |
2 |
0.0025 |
| 195 |
ARTERY DISSECTION |
1 |
0.0024 |
| 196 |
SEIZURE CLUSTER |
2 |
0.0024 |
| 197 |
CANDIDA TEST POSITIVE |
1 |
0.0024 |
| 198 |
BRADYCARDIA NEONATAL |
3 |
0.0024 |
| 199 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
2 |
0.0024 |
| 200 |
RAPID EYE MOVEMENTS SLEEP ABNORMAL |
1 |
0.0024 |
| 201 |
APGAR SCORE LOW |
3 |
0.0023 |
| 202 |
SLOW RESPONSE TO STIMULI |
3 |
0.0023 |
| 203 |
SARCOPENIA |
1 |
0.0023 |
| 204 |
HYPOTONIA |
23 |
0.0023 |
| 205 |
VENTRICULAR FIBRILLATION |
25 |
0.0022 |
| 206 |
HYPERLACTACIDAEMIA |
6 |
0.0022 |
| 207 |
RESPIRATORY RATE DECREASED |
7 |
0.0022 |
| 208 |
PROTEIN URINE |
2 |
0.0022 |
| 209 |
POLYURIA |
18 |
0.0022 |
| 210 |
LOCKED-IN SYNDROME |
1 |
0.0022 |
| 211 |
CEREBRAL HYPOPERFUSION |
1 |
0.0021 |
| 212 |
ENDOTRACHEAL INTUBATION |
6 |
0.0021 |
| 213 |
MYOCLONUS |
25 |
0.0021 |
| 214 |
PNEUMONIA HAEMOPHILUS |
1 |
0.0021 |
| 215 |
MOTOR NEURONE DISEASE |
1 |
0.0021 |
| 216 |
ELECTROLYTE DEPLETION |
1 |
0.0020 |
| 217 |
GENERALISED TONIC-CLONIC SEIZURE |
33 |
0.0020 |
| 218 |
HYPERCAPNIA |
6 |
0.0020 |
| 219 |
SHUNT OCCLUSION |
1 |
0.0020 |
| 220 |
HAEMODYNAMIC INSTABILITY |
15 |
0.0020 |
| 221 |
BRUGADA SYNDROME |
2 |
0.0019 |
| 222 |
PULSELESS ELECTRICAL ACTIVITY |
8 |
0.0019 |
| 223 |
STRESS CARDIOMYOPATHY |
11 |
0.0019 |
| 224 |
LOCAL ANAESTHETIC SYSTEMIC TOXICITY |
2 |
0.0019 |
| 225 |
ASTERIXIS |
2 |
0.0019 |
| 226 |
JOINT CONTRACTURE |
2 |
0.0019 |
| 227 |
EPIGLOTTITIS |
1 |
0.0018 |
| 228 |
PRODUCT NAME CONFUSION |
2 |
0.0018 |
| 229 |
ARRHYTHMIA SUPRAVENTRICULAR |
2 |
0.0018 |
| 230 |
RIGHT VENTRICULAR DYSFUNCTION |
2 |
0.0018 |
| 231 |
ACCIDENT AT WORK |
4 |
0.0018 |
| 232 |
PRODUCT CLOSURE ISSUE |
1 |
0.0018 |
| 233 |
BLOOD FIBRINOGEN DECREASED |
2 |
0.0018 |
| 234 |
FLASHBACK |
1 |
0.0017 |
| 235 |
MEDIASTINITIS |
1 |
0.0017 |
| 236 |
HYPERBILIRUBINAEMIA NEONATAL |
1 |
0.0017 |
| 237 |
SINUS NODE DYSFUNCTION |
3 |
0.0016 |
| 238 |
VENTRICULAR TACHYCARDIA |
27 |
0.0016 |
| 239 |
INFUSION SITE WARMTH |
2 |
0.0016 |
| 240 |
PARADOXICAL DRUG REACTION |
6 |
0.0016 |
| 241 |
TACHYPNOEA |
22 |
0.0016 |
| 242 |
DIAPHRAGMATIC HERNIA |
1 |
0.0016 |
| 243 |
FOETAL HEART RATE DECREASED |
1 |
0.0016 |
| 244 |
HYPOTHERMIA |
16 |
0.0016 |
| 245 |
BRONCHIAL SECRETION RETENTION |
2 |
0.0016 |
| 246 |
ABDOMINAL COMPARTMENT SYNDROME |
1 |
0.0016 |
| 247 |
COMMUNICATION DISORDER |
6 |
0.0016 |
| 248 |
CHOLINERGIC SYNDROME |
1 |
0.0016 |
| 249 |
INCREASED BRONCHIAL SECRETION |
4 |
0.0016 |
| 250 |
ENTEROCOCCUS TEST POSITIVE |
1 |
0.0015 |
| 251 |
PROCEDURAL VOMITING |
1 |
0.0015 |
| 252 |
KLEBSIELLA TEST POSITIVE |
1 |
0.0015 |
| 253 |
HYPERAEMIA |
3 |
0.0015 |
| 254 |
LUNG TRANSPLANT REJECTION |
1 |
0.0015 |
| 255 |
DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED |
1 |
0.0015 |
| 256 |
BRADYPNOEA |
4 |
0.0015 |
| 257 |
PARANEOPLASTIC SYNDROME |
1 |
0.0015 |
| 258 |
CHOREOATHETOSIS |
1 |
0.0015 |
| 259 |
CYTOKINE STORM |
1 |
0.0015 |
| 260 |
ANASTOMOTIC LEAK |
1 |
0.0014 |
| 261 |
HYPOPNOEA |
5 |
0.0014 |
| 262 |
PEPTIC ULCER HAEMORRHAGE |
1 |
0.0014 |
| 263 |
CRANIAL NERVE DISORDER |
1 |
0.0014 |
| 264 |
FOETAL HEART RATE DECELERATION ABNORMALITY |
1 |
0.0014 |
| 265 |
ELECTROCARDIOGRAM ST-T CHANGE |
1 |
0.0014 |
| 266 |
DEVICE ELECTRICAL FINDING |
1 |
0.0014 |
| 267 |
TONIC CONVULSION |
2 |
0.0014 |
| 268 |
PORPHYRIA ACUTE |
2 |
0.0014 |
| 269 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
1 |
0.0014 |
| 270 |
CHYLOTHORAX |
1 |
0.0014 |
| 271 |
AMNIOTIC CAVITY INFECTION |
1 |
0.0014 |
| 272 |
GASTRIC MUCOSAL LESION |
1 |
0.0014 |
| 273 |
CARDIAC ARREST |
113 |
0.0014 |
| 274 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
3 |
0.0014 |
| 275 |
DRUG-DISEASE INTERACTION |
1 |
0.0014 |
| 276 |
STRIDOR |
4 |
0.0014 |
| 277 |
CEREBRAL VASOCONSTRICTION |
1 |
0.0014 |
| 278 |
INFUSION SITE INDURATION |
2 |
0.0013 |
| 279 |
HISTIOCYTOSIS HAEMATOPHAGIC |
4 |
0.0013 |
| 280 |
BLOOD PRESSURE IMMEASURABLE |
2 |
0.0013 |
| 281 |
NEUROLOGICAL DECOMPENSATION |
3 |
0.0013 |
| 282 |
CRITICAL ILLNESS |
1 |
0.0013 |
| 283 |
BLOOD FIBRINOGEN INCREASED |
1 |
0.0013 |
| 284 |
BRONCHOPULMONARY DYSPLASIA |
1 |
0.0012 |
| 285 |
ENTEROCOCCAL SEPSIS |
1 |
0.0012 |
| 286 |
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
4 |
0.0012 |
| 287 |
RESPIRATORY ALKALOSIS |
2 |
0.0012 |
| 288 |
FEAR OF FALLING |
1 |
0.0012 |
| 289 |
PSEUDOMONAS TEST POSITIVE |
1 |
0.0012 |
| 290 |
ACUTE PSYCHOSIS |
3 |
0.0012 |
| 291 |
CIRCADIAN RHYTHM SLEEP DISORDER |
1 |
0.0012 |
| 292 |
OESOPHAGEAL PERFORATION |
1 |
0.0012 |
| 293 |
HYPERAMMONAEMIA |
6 |
0.0012 |
| 294 |
INFUSION SITE OEDEMA |
1 |
0.0012 |
| 295 |
ASPIRATION |
13 |
0.0012 |
| 296 |
OBSTRUCTIVE AIRWAYS DISORDER |
13 |
0.0012 |
| 297 |
MALIGNANT HYPERTENSION |
1 |
0.0012 |
| 298 |
EOSINOPHILIC PNEUMONIA ACUTE |
1 |
0.0012 |
| 299 |
OESOPHAGEAL OBSTRUCTION |
1 |
0.0012 |
| 300 |
DERMATITIS EXFOLIATIVE GENERALISED |
4 |
0.0011 |
| 301 |
URINE OUTPUT INCREASED |
3 |
0.0011 |
| 302 |
CEREBELLAR ATROPHY |
1 |
0.0011 |
| 303 |
ENTEROCUTANEOUS FISTULA |
1 |
0.0011 |
| 304 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
3 |
0.0011 |
| 305 |
ILEUS |
14 |
0.0011 |
| 306 |
CYTOMEGALOVIRUS TEST POSITIVE |
2 |
0.0011 |
| 307 |
MIOSIS |
9 |
0.0011 |
| 308 |
CANDIDA SEPSIS |
1 |
0.0011 |
| 309 |
IMMUNE-MEDIATED LUNG DISEASE |
2 |
0.0011 |
| 310 |
ANEURYSM RUPTURED |
1 |
0.0011 |
| 311 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
1 |
0.0011 |
| 312 |
OXYGEN SATURATION DECREASED |
60 |
0.0011 |
| 313 |
STEREOTYPY |
1 |
0.0011 |
| 314 |
BRAIN STEM HAEMORRHAGE |
1 |
0.0011 |
| 315 |
HEPATIC CONGESTION |
1 |
0.0011 |
| 316 |
OXYGEN SATURATION ABNORMAL |
3 |
0.0011 |
| 317 |
ELECTROCARDIOGRAM CHANGE |
1 |
0.0011 |
| 318 |
CEREBRAL PALSY |
1 |
0.0011 |
| 319 |
CARDIAC TAMPONADE |
5 |
0.0011 |
| 320 |
PULSE ABSENT |
5 |
0.0011 |
| 321 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
10 |
0.0010 |
| 322 |
AGITATION NEONATAL |
1 |
0.0010 |
| 323 |
ATRIOVENTRICULAR BLOCK |
8 |
0.0010 |
| 324 |
BLADDER CATHETERISATION |
1 |
0.0010 |
| 325 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
3 |
0.0010 |
| 326 |
WITHDRAWAL SYNDROME |
43 |
0.0010 |
| 327 |
CONTINUOUS HAEMODIAFILTRATION |
1 |
0.0010 |
| 328 |
EYE MOVEMENT DISORDER |
7 |
0.0010 |
| 329 |
IDIOSYNCRATIC DRUG REACTION |
1 |
0.0010 |
| 330 |
ALTERED STATE OF CONSCIOUSNESS |
22 |
0.0010 |
| 331 |
ADMINISTRATION SITE EXTRAVASATION |
1 |
0.0010 |
| 332 |
MUCOSAL DRYNESS |
2 |
0.0010 |
| 333 |
FALSE POSITIVE INVESTIGATION RESULT |
1 |
0.0010 |
| 334 |
HYPERTENSIVE CRISIS |
11 |
0.0010 |
| 335 |
DRUG TOLERANCE |
5 |
0.0010 |
| 336 |
DYSPHORIA |
5 |
0.0010 |
| 337 |
HYPOCHROMIC ANAEMIA |
1 |
0.0010 |
| 338 |
TOXIC ENCEPHALOPATHY |
5 |
0.0010 |
| 339 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
1 |
0.0010 |
| 340 |
QUADRIPLEGIA |
2 |
0.0010 |
| 341 |
SUBILEUS |
2 |
0.0010 |
| 342 |
STAPHYLOCOCCUS TEST POSITIVE |
2 |
0.0009 |
| 343 |
DEVICE INEFFECTIVE |
1 |
0.0009 |
| 344 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
16 |
0.0009 |
| 345 |
OCULOGYRIC CRISIS |
2 |
0.0009 |
| 346 |
ATELECTASIS |
9 |
0.0009 |
| 347 |
HYPERPHOSPHATAEMIA |
2 |
0.0009 |
| 348 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
4 |
0.0009 |
| 349 |
HYPOVENTILATION |
3 |
0.0009 |
| 350 |
CARDIAC HYPERTROPHY |
1 |
0.0009 |
| 351 |
HEART RATE ABNORMAL |
5 |
0.0009 |
| 352 |
ILEUS PARALYTIC |
4 |
0.0009 |
| 353 |
ANAPHYLACTIC SHOCK |
23 |
0.0009 |
| 354 |
SUPRAVENTRICULAR EXTRASYSTOLES |
3 |
0.0009 |
| 355 |
GASTROINTESTINAL HYPOMOTILITY |
2 |
0.0009 |
| 356 |
SUSPECTED OFF LABEL USE |
4 |
0.0009 |
| 357 |
KOUNIS SYNDROME |
2 |
0.0009 |
| 358 |
ACCIDENTAL OVERDOSE |
32 |
0.0009 |
| 359 |
BUNDLE BRANCH BLOCK RIGHT |
4 |
0.0009 |
| 360 |
PAROTITIS |
1 |
0.0009 |
| 361 |
ELECTROCARDIOGRAM QT PROLONGED |
31 |
0.0009 |
| 362 |
ISCHAEMIC CEREBRAL INFARCTION |
1 |
0.0009 |
| 363 |
ACUTE LUNG INJURY |
1 |
0.0008 |
| 364 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
1 |
0.0008 |
| 365 |
CHRONIC RESPIRATORY FAILURE |
1 |
0.0008 |
| 366 |
BLEEDING TIME PROLONGED |
1 |
0.0008 |
| 367 |
STARING |
2 |
0.0008 |
| 368 |
PHARYNGEAL HAEMORRHAGE |
1 |
0.0008 |
| 369 |
HYPOXIA |
28 |
0.0008 |
| 370 |
NEUTROPHIL PERCENTAGE INCREASED |
1 |
0.0008 |
| 371 |
MYOCARDIAL ISCHAEMIA |
9 |
0.0008 |
| 372 |
BLOOD BILIRUBIN ABNORMAL |
1 |
0.0008 |
| 373 |
DELIRIUM |
27 |
0.0008 |
| 374 |
SINUS TACHYCARDIA |
11 |
0.0008 |
| 375 |
THERAPY PARTIAL RESPONDER |
12 |
0.0008 |
| 376 |
SINUS ARRHYTHMIA |
1 |
0.0008 |
| 377 |
CARDIOGENIC SHOCK |
11 |
0.0008 |
| 378 |
DRUG CLEARANCE DECREASED |
1 |
0.0008 |
| 379 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
2 |
0.0008 |
| 380 |
NEUROLEPTIC MALIGNANT SYNDROME |
9 |
0.0008 |
| 381 |
LYMPHOCYTE PERCENTAGE DECREASED |
1 |
0.0007 |
| 382 |
EXTRAVASATION |
3 |
0.0007 |
| 383 |
INFUSION SITE RASH |
1 |
0.0007 |
| 384 |
RED BLOOD CELL COUNT INCREASED |
2 |
0.0007 |
| 385 |
ECHOCARDIOGRAM ABNORMAL |
1 |
0.0007 |
| 386 |
H1N1 INFLUENZA |
1 |
0.0007 |
| 387 |
CULTURE URINE POSITIVE |
1 |
0.0007 |
| 388 |
ANTICONVULSANT DRUG LEVEL DECREASED |
1 |
0.0007 |
| 389 |
CHOLECYSTITIS ACUTE |
4 |
0.0007 |
| 390 |
INCORRECT DRUG ADMINISTRATION RATE |
3 |
0.0007 |
| 391 |
CIRCULATORY COLLAPSE |
12 |
0.0007 |
| 392 |
HYPERVENTILATION |
4 |
0.0007 |
| 393 |
HAEMOTHORAX |
2 |
0.0007 |
| 394 |
PRODUCT LABEL CONFUSION |
4 |
0.0007 |
| 395 |
THERAPEUTIC REACTION TIME DECREASED |
2 |
0.0007 |
| 396 |
CEREBRAL DISORDER |
5 |
0.0007 |
| 397 |
VENTRICULAR EXTRASYSTOLES |
7 |
0.0007 |
| 398 |
AGITATION |
49 |
0.0007 |
| 399 |
MIXED LIVER INJURY |
2 |
0.0007 |
| 400 |
EMBOLISM VENOUS |
2 |
0.0007 |
| 401 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
0.0007 |
| 402 |
ACIDOSIS |
5 |
0.0007 |
| 403 |
MYOGLOBIN BLOOD INCREASED |
1 |
0.0007 |
| 404 |
RHABDOMYOLYSIS |
27 |
0.0006 |
| 405 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
1 |
0.0006 |
| 406 |
ANTICHOLINERGIC SYNDROME |
1 |
0.0006 |
| 407 |
SUPRAVENTRICULAR TACHYCARDIA |
6 |
0.0006 |
| 408 |
DISINHIBITION |
1 |
0.0006 |
| 409 |
SEDATION |
16 |
0.0006 |
| 410 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 411 |
PNEUMONIA ASPIRATION |
15 |
0.0006 |
| 412 |
GAZE PALSY |
1 |
0.0006 |
| 413 |
WOUND COMPLICATION |
2 |
0.0006 |
| 414 |
UNRESPONSIVE TO STIMULI |
15 |
0.0006 |
| 415 |
SHOCK |
13 |
0.0006 |
| 416 |
MITRAL VALVE DISEASE |
1 |
0.0006 |
| 417 |
FIBRIN D DIMER INCREASED |
2 |
0.0006 |
| 418 |
PARAPARESIS |
1 |
0.0006 |
| 419 |
GRAFT VERSUS HOST DISEASE |
4 |
0.0006 |
| 420 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
22 |
0.0006 |
| 421 |
PNEUMOMEDIASTINUM |
1 |
0.0006 |
| 422 |
DEVICE ALARM ISSUE |
1 |
0.0006 |
| 423 |
HYPERGLYCAEMIA |
20 |
0.0005 |
| 424 |
MEAN CELL HAEMOGLOBIN DECREASED |
1 |
0.0005 |
| 425 |
CONDUCTION DISORDER |
1 |
0.0005 |
| 426 |
DRUG LEVEL INCREASED |
9 |
0.0005 |
| 427 |
AMYLASE INCREASED |
2 |
0.0005 |
| 428 |
PUPILLARY REFLEX IMPAIRED |
1 |
0.0005 |
| 429 |
MENTAL STATUS CHANGES |
15 |
0.0005 |
| 430 |
CATHETER PLACEMENT |
1 |
0.0005 |
| 431 |
LYMPH NODE PAIN |
1 |
0.0005 |
| 432 |
LEUKOENCEPHALOPATHY |
2 |
0.0005 |
| 433 |
RESPIRATORY FAILURE |
39 |
0.0005 |
| 434 |
ACUTE PULMONARY OEDEMA |
3 |
0.0005 |
| 435 |
ADENOCARCINOMA OF COLON |
1 |
0.0005 |
| 436 |
STENOSIS |
1 |
0.0005 |
| 437 |
JAUNDICE NEONATAL |
1 |
0.0005 |
| 438 |
TOXIC EPIDERMAL NECROLYSIS |
8 |
0.0005 |
| 439 |
MECHANICAL VENTILATION |
1 |
0.0005 |
| 440 |
HYPERCOAGULATION |
1 |
0.0005 |
| 441 |
PROCEDURAL COMPLICATION |
4 |
0.0005 |
| 442 |
CHOLESTASIS |
10 |
0.0005 |
| 443 |
ELECTROLYTE IMBALANCE |
6 |
0.0005 |
| 444 |
CARDIOPULMONARY FAILURE |
2 |
0.0005 |
| 445 |
HEART RATE DECREASED |
18 |
0.0005 |
| 446 |
MULTI-ORGAN DISORDER |
1 |
0.0005 |
| 447 |
DISSEMINATED INTRAVASCULAR COAGULATION |
7 |
0.0005 |
| 448 |
TACHYCARDIA |
43 |
0.0005 |
| 449 |
HYPOTENSION |
97 |
0.0005 |
| 450 |
LIVEDO RETICULARIS |
1 |
0.0005 |
| 451 |
LUNG ABSCESS |
1 |
0.0005 |
| 452 |
ATRIAL TACHYCARDIA |
1 |
0.0005 |
| 453 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0005 |
| 454 |
RESPIRATORY ARREST |
13 |
0.0005 |
| 455 |
RESPIRATORY DISTRESS |
13 |
0.0005 |
| 456 |
RADIATION PNEUMONITIS |
1 |
0.0005 |
| 457 |
CATHETER SITE ERYTHEMA |
1 |
0.0005 |
| 458 |
BLOOD PRESSURE DECREASED |
31 |
0.0005 |
| 459 |
SEPTIC SHOCK |
20 |
0.0005 |
| 460 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
13 |
0.0005 |
| 461 |
CARDIO-RESPIRATORY ARREST |
19 |
0.0005 |
| 462 |
GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0005 |
| 463 |
DRUG INTERACTION |
72 |
0.0005 |
| 464 |
CLOSTRIDIUM TEST POSITIVE |
1 |
0.0005 |
| 465 |
CARDIAC FAILURE ACUTE |
3 |
0.0004 |
| 466 |
CEREBRAL INFARCTION |
11 |
0.0004 |
| 467 |
STATUS EPILEPTICUS |
5 |
0.0004 |
| 468 |
METASTASES TO MENINGES |
1 |
0.0004 |
| 469 |
BLOOD PRESSURE SYSTOLIC DECREASED |
2 |
0.0004 |
| 470 |
RESPIRATION ABNORMAL |
3 |
0.0004 |
| 471 |
HAEMOLYTIC URAEMIC SYNDROME |
1 |
0.0004 |
| 472 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 473 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
11 |
0.0004 |
| 474 |
LACERATION |
4 |
0.0004 |
| 475 |
CONTRAST MEDIA REACTION |
1 |
0.0004 |
| 476 |
HYPOVOLAEMIC SHOCK |
2 |
0.0004 |
| 477 |
THROMBOTIC MICROANGIOPATHY |
4 |
0.0004 |
| 478 |
ENCEPHALOPATHY |
10 |
0.0004 |
| 479 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
2 |
0.0004 |
| 480 |
INTRAVENTRICULAR HAEMORRHAGE |
1 |
0.0004 |
| 481 |
CORONARY ARTERY STENOSIS |
2 |
0.0004 |
| 482 |
EXCORIATION |
1 |
0.0004 |
| 483 |
HEPATIC CYTOLYSIS |
5 |
0.0004 |
| 484 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 485 |
ABDOMINAL INFECTION |
1 |
0.0004 |
| 486 |
FEMORAL NECK FRACTURE |
2 |
0.0004 |
| 487 |
BRONCHOPULMONARY ASPERGILLOSIS |
3 |
0.0004 |
| 488 |
MALABSORPTION |
2 |
0.0004 |
| 489 |
APLASTIC ANAEMIA |
2 |
0.0004 |
| 490 |
PARTIAL SEIZURES |
2 |
0.0004 |
| 491 |
HYPERSENSITIVITY VASCULITIS |
1 |
0.0004 |
| 492 |
CATATONIA |
2 |
0.0004 |
| 493 |
RADICULOPATHY |
1 |
0.0004 |
| 494 |
ATRIAL FLUTTER |
3 |
0.0004 |
| 495 |
ALCOHOL POISONING |
1 |
0.0004 |
| 496 |
ANAESTHETIC COMPLICATION |
1 |
0.0004 |
| 497 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 498 |
HICCUPS |
3 |
0.0004 |
| 499 |
PRODUCT USE IN UNAPPROVED INDICATION |
90 |
0.0004 |
| 500 |
IMMUNE-MEDIATED MYOSITIS |
1 |
0.0004 |
| 501 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0004 |
| 502 |
RASH MORBILLIFORM |
1 |
0.0004 |
| 503 |
MACULE |
1 |
0.0004 |
| 504 |
PULMONARY ALVEOLAR HAEMORRHAGE |
2 |
0.0004 |
| 505 |
ANTIPSYCHOTIC DRUG LEVEL INCREASED |
1 |
0.0004 |
| 506 |
DRUG WITHDRAWAL SYNDROME |
31 |
0.0004 |
| 507 |
HEPATOCELLULAR INJURY |
5 |
0.0004 |
| 508 |
RESPIRATORY SYMPTOM |
1 |
0.0004 |
| 509 |
SPEECH DISORDER DEVELOPMENTAL |
1 |
0.0003 |
| 510 |
ADENOVIRUS INFECTION |
1 |
0.0003 |
| 511 |
METABOLIC ACIDOSIS |
11 |
0.0003 |
| 512 |
URINE OUTPUT DECREASED |
3 |
0.0003 |
| 513 |
DEVICE POWER SOURCE ISSUE |
1 |
0.0003 |
| 514 |
BACTERAEMIA |
4 |
0.0003 |
| 515 |
HEPATITIS FULMINANT |
1 |
0.0003 |
| 516 |
BRAIN HERNIATION |
1 |
0.0003 |
| 517 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 518 |
HAEMORRHAGE INTRACRANIAL |
5 |
0.0003 |
| 519 |
PROTHROMBIN TIME PROLONGED |
2 |
0.0003 |
| 520 |
METABOLIC ENCEPHALOPATHY |
1 |
0.0003 |
| 521 |
FOETAL GROWTH RESTRICTION |
2 |
0.0003 |
| 522 |
RESTLESSNESS |
12 |
0.0003 |
| 523 |
DIASTOLIC DYSFUNCTION |
1 |
0.0003 |
| 524 |
INFUSION SITE SWELLING |
2 |
0.0003 |
| 525 |
HYPOCALCAEMIA |
6 |
0.0003 |
| 526 |
PRODUCT USE ISSUE |
59 |
0.0003 |
| 527 |
ACUTE RESPIRATORY FAILURE |
6 |
0.0003 |
| 528 |
SKIN EROSION |
1 |
0.0003 |
| 529 |
DYSTONIA |
6 |
0.0003 |
| 530 |
FEBRILE NEUTROPENIA |
20 |
0.0003 |
| 531 |
MENINGITIS |
2 |
0.0003 |
| 532 |
PROSTATE CANCER METASTATIC |
1 |
0.0003 |
| 533 |
BLOOD UREA INCREASED |
5 |
0.0003 |
| 534 |
LEFT VENTRICULAR DYSFUNCTION |
2 |
0.0003 |
| 535 |
POTENTIATING DRUG INTERACTION |
1 |
0.0003 |
| 536 |
PRODUCT ADMINISTRATION ERROR |
6 |
0.0003 |
| 537 |
SUBARACHNOID HAEMORRHAGE |
3 |
0.0003 |
| 538 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
2 |
0.0003 |
| 539 |
BODY TEMPERATURE INCREASED |
6 |
0.0003 |
| 540 |
BRONCHOPNEUMONIA |
1 |
0.0003 |
| 541 |
BLOOD PRESSURE FLUCTUATION |
7 |
0.0003 |
| 542 |
LEFT VENTRICULAR FAILURE |
1 |
0.0003 |
| 543 |
DROOLING |
2 |
0.0003 |
| 544 |
DRUG-INDUCED LIVER INJURY |
9 |
0.0003 |
| 545 |
BRONCHIOLITIS |
1 |
0.0003 |
| 546 |
JAUNDICE CHOLESTATIC |
1 |
0.0003 |
| 547 |
CLOSTRIDIUM DIFFICILE COLITIS |
3 |
0.0003 |
| 548 |
FACIAL PARESIS |
1 |
0.0003 |
| 549 |
HYPOKALAEMIA |
13 |
0.0003 |
| 550 |
HAEMORRHAGIC DIATHESIS |
1 |
0.0003 |
| 551 |
CONJUNCTIVAL HYPERAEMIA |
1 |
0.0003 |
| 552 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
8 |
0.0003 |
| 553 |
APPARENT DEATH |
1 |
0.0003 |
| 554 |
RESTLESS LEGS SYNDROME |
5 |
0.0003 |
| 555 |
CAROTID ARTERY OCCLUSION |
1 |
0.0003 |
| 556 |
CUTANEOUS VASCULITIS |
1 |
0.0003 |
| 557 |
MOUTH HAEMORRHAGE |
2 |
0.0003 |
| 558 |
BLOOD PRESSURE DIASTOLIC DECREASED |
2 |
0.0003 |
| 559 |
DYSKINESIA |
11 |
0.0003 |
| 560 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 561 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 562 |
REBOUND EFFECT |
3 |
0.0003 |
| 563 |
CATHETER SITE INFECTION |
1 |
0.0003 |
| 564 |
OESOPHAGEAL ULCER |
1 |
0.0003 |
| 565 |
DIFFUSE LARGE B-CELL LYMPHOMA |
2 |
0.0003 |
| 566 |
PROCEDURAL HAEMORRHAGE |
1 |
0.0003 |
| 567 |
TOXICITY TO VARIOUS AGENTS |
43 |
0.0003 |
| 568 |
COVID-19 PNEUMONIA |
3 |
0.0003 |
| 569 |
BLOOD ALBUMIN DECREASED |
2 |
0.0003 |
| 570 |
PATENT DUCTUS ARTERIOSUS |
1 |
0.0003 |
| 571 |
LOW BIRTH WEIGHT BABY |
2 |
0.0003 |
| 572 |
CEREBRAL ATROPHY |
1 |
0.0003 |
| 573 |
MUSCLE RIGIDITY |
3 |
0.0003 |
| 574 |
SYNCOPE |
25 |
0.0002 |
| 575 |
IRRITABILITY |
15 |
0.0002 |
| 576 |
CANDIDIASIS |
1 |
0.0002 |
| 577 |
MYASTHENIA GRAVIS |
2 |
0.0002 |
| 578 |
HYPERAESTHESIA |
2 |
0.0002 |
| 579 |
HYPERURICAEMIA |
1 |
0.0002 |
| 580 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 581 |
EXTRAPYRAMIDAL DISORDER |
6 |
0.0002 |
| 582 |
INFUSION SITE ERYTHEMA |
2 |
0.0002 |
| 583 |
ANAPHYLACTIC REACTION |
13 |
0.0002 |
| 584 |
LEFT VENTRICULAR HYPERTROPHY |
1 |
0.0002 |
| 585 |
ANURIA |
2 |
0.0002 |
| 586 |
MULTI-ORGAN FAILURE |
4 |
0.0002 |
| 587 |
MONOPLEGIA |
1 |
0.0002 |
| 588 |
PULMONARY CONGESTION |
3 |
0.0002 |
| 589 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 590 |
PURPURA |
2 |
0.0002 |
| 591 |
SEIZURE |
26 |
0.0002 |
| 592 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 593 |
LOSS OF CONSCIOUSNESS |
28 |
0.0002 |
| 594 |
ACUTE GRAFT VERSUS HOST DISEASE |
1 |
0.0002 |
| 595 |
ISCHAEMIA |
1 |
0.0002 |
| 596 |
INTERCEPTED MEDICATION ERROR |
1 |
0.0002 |
| 597 |
SEPSIS |
24 |
0.0002 |
| 598 |
HEPATIC FUNCTION ABNORMAL |
8 |
0.0002 |
| 599 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
15 |
0.0002 |
| 600 |
SEROTONIN SYNDROME |
4 |
0.0002 |
| 601 |
RENAL CELL CARCINOMA |
1 |
0.0002 |
| 602 |
HEPATOMEGALY |
2 |
0.0002 |
| 603 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 604 |
PYREXIA |
70 |
0.0002 |
| 605 |
INFLAMMATORY MARKER INCREASED |
1 |
0.0002 |
| 606 |
RESPIRATORY DISORDER |
6 |
0.0002 |
| 607 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
11 |
0.0002 |
| 608 |
SALIVARY HYPERSECRETION |
2 |
0.0002 |
| 609 |
BRAIN INJURY |
2 |
0.0002 |
| 610 |
PREMATURE BABY |
6 |
0.0002 |
| 611 |
OVERDOSE |
43 |
0.0002 |
| 612 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 613 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
1 |
0.0002 |
| 614 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
1 |
0.0002 |
| 615 |
CACHEXIA |
1 |
0.0002 |
| 616 |
LUNG INFECTION |
3 |
0.0002 |
| 617 |
HYPERBILIRUBINAEMIA |
2 |
0.0002 |
| 618 |
SKIN NECROSIS |
1 |
0.0002 |
| 619 |
SERUM FERRITIN INCREASED |
1 |
0.0002 |
| 620 |
SOMNOLENCE |
38 |
0.0002 |
| 621 |
INTERSTITIAL LUNG DISEASE |
9 |
0.0002 |
| 622 |
ATRIAL FIBRILLATION |
18 |
0.0002 |
| 623 |
HYDROCEPHALUS |
1 |
0.0002 |
| 624 |
WHITE BLOOD CELL COUNT INCREASED |
7 |
0.0002 |
| 625 |
INTESTINAL ISCHAEMIA |
1 |
0.0002 |
| 626 |
GASTRIC ULCER HAEMORRHAGE |
1 |
0.0002 |
| 627 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 628 |
OFF LABEL USE |
157 |
0.0002 |
| 629 |
PULMONARY OEDEMA |
8 |
0.0002 |
| 630 |
INTESTINAL PERFORATION |
2 |
0.0002 |
| 631 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 632 |
CORONARY ARTERY BYPASS |
1 |
0.0002 |
| 633 |
GASTRIC HAEMORRHAGE |
2 |
0.0002 |
| 634 |
RALES |
1 |
0.0002 |
| 635 |
METABOLIC DISORDER |
1 |
0.0002 |
| 636 |
ACUTE KIDNEY INJURY |
26 |
0.0002 |
| 637 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
3 |
0.0002 |
| 638 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
1 |
0.0002 |
| 639 |
ATAXIA |
2 |
0.0002 |
| 640 |
PLEURISY |
1 |
0.0002 |
| 641 |
COMA |
8 |
0.0002 |
| 642 |
ADRENAL INSUFFICIENCY |
2 |
0.0002 |
| 643 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 644 |
NO THERAPEUTIC RESPONSE |
2 |
0.0002 |
| 645 |
EPILEPSY |
5 |
0.0002 |
| 646 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 647 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 648 |
HYPERCALCAEMIA |
2 |
0.0002 |
| 649 |
OLIGURIA |
1 |
0.0002 |
| 650 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 651 |
PROCTALGIA |
1 |
0.0002 |
| 652 |
HEPATITIS ACUTE |
1 |
0.0002 |
| 653 |
ANGINA UNSTABLE |
1 |
0.0002 |
| 654 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 655 |
HYPOGAMMAGLOBULINAEMIA |
1 |
0.0002 |
| 656 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
0.0002 |
| 657 |
PLATELET COUNT DECREASED |
16 |
0.0001 |
| 658 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 659 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 660 |
BLOOD BILIRUBIN INCREASED |
4 |
0.0001 |
| 661 |
PLEURAL EFFUSION |
9 |
0.0001 |
| 662 |
IMPAIRED GASTRIC EMPTYING |
2 |
0.0001 |
| 663 |
ABNORMAL LOSS OF WEIGHT |
1 |
0.0001 |
| 664 |
ACUTE HEPATIC FAILURE |
2 |
0.0001 |
| 665 |
ENCEPHALITIS |
1 |
0.0001 |
| 666 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 667 |
HYPOMAGNESAEMIA |
2 |
0.0001 |
| 668 |
COORDINATION ABNORMAL |
2 |
0.0001 |
| 669 |
PAPULE |
1 |
0.0001 |
| 670 |
DUODENAL ULCER |
1 |
0.0001 |
| 671 |
HYPERTENSION |
30 |
0.0001 |
| 672 |
METASTASIS |
1 |
0.0001 |
| 673 |
AGGRESSION |
7 |
0.0001 |
| 674 |
LIVER FUNCTION TEST INCREASED |
3 |
0.0001 |
| 675 |
DERMATITIS BULLOUS |
1 |
0.0001 |
| 676 |
C-REACTIVE PROTEIN INCREASED |
5 |
0.0001 |
| 677 |
MELAENA |
3 |
0.0001 |
| 678 |
CARDIOMYOPATHY |
2 |
0.0001 |
| 679 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 680 |
LIVER DISORDER |
6 |
0.0001 |
| 681 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
1 |
0.0001 |
| 682 |
DYSARTHRIA |
5 |
0.0001 |
| 683 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 684 |
HAEMOLYSIS |
1 |
0.0001 |
| 685 |
CONCUSSION |
1 |
0.0001 |
| 686 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 687 |
COGNITIVE DISORDER |
6 |
0.0001 |
| 688 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 689 |
CYANOSIS |
2 |
0.0001 |
| 690 |
ARRHYTHMIA |
6 |
0.0001 |
| 691 |
DRUG SCREEN POSITIVE |
1 |
0.0001 |
| 692 |
PNEUMOTHORAX |
2 |
0.0001 |
| 693 |
RENAL CYST |
1 |
0.0001 |
| 694 |
BLOOD DISORDER |
1 |
0.0001 |
| 695 |
MUSCLE TIGHTNESS |
2 |
0.0001 |
| 696 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 697 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 698 |
DECUBITUS ULCER |
1 |
0.0001 |
| 699 |
NEUTROPHIL COUNT DECREASED |
5 |
0.0001 |
| 700 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 701 |
COAGULOPATHY |
2 |
0.0001 |
| 702 |
EOSINOPHIL COUNT INCREASED |
1 |
0.0001 |
| 703 |
RENAL IMPAIRMENT |
10 |
0.0001 |
| 704 |
PRODUCT COMPLAINT |
3 |
0.0001 |
| 705 |
HEMIPARESIS |
2 |
0.0001 |
| 706 |
INADEQUATE ANALGESIA |
1 |
0.0001 |
| 707 |
SCAR |
2 |
0.0001 |
| 708 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 709 |
NEUROTOXICITY |
2 |
0.0001 |
| 710 |
EOSINOPHILIA |
2 |
0.0001 |
| 711 |
CARDIOTOXICITY |
1 |
0.0001 |
| 712 |
CEREBRAL HAEMORRHAGE |
4 |
0.0001 |
| 713 |
FOETAL EXPOSURE DURING PREGNANCY |
9 |
0.0001 |
| 714 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 715 |
PALLOR |
3 |
0.0001 |
| 716 |
PNEUMONITIS |
3 |
0.0001 |
| 717 |
MOOD ALTERED |
3 |
0.0001 |
| 718 |
PNEUMONIA |
35 |
0.0001 |
| 719 |
BLOOD CREATININE INCREASED |
7 |
0.0001 |
| 720 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 721 |
PROTEINURIA |
2 |
0.0001 |
| 722 |
RED BLOOD CELL COUNT DECREASED |
3 |
0.0001 |
| 723 |
LETHARGY |
6 |
0.0001 |
| 724 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
0.0001 |
| 725 |
ACUTE MYOCARDIAL INFARCTION |
3 |
0.0001 |
| 726 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 727 |
DISEASE PROGRESSION |
12 |
0.0001 |
| 728 |
DISORIENTATION |
4 |
0.0001 |
| 729 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 730 |
APHASIA |
3 |
0.0001 |
| 731 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 732 |
RENAL FAILURE |
13 |
0.0001 |
| 733 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 734 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 735 |
EAR DISCOMFORT |
1 |
0.0001 |
| 736 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
1 |
0.0001 |
| 737 |
EYE DISCHARGE |
1 |
0.0001 |
| 738 |
INTENTIONAL DRUG MISUSE |
2 |
0.0001 |
| 739 |
ANAEMIA |
18 |
0.0001 |
| 740 |
BREAST CANCER METASTATIC |
1 |
0.0001 |
| 741 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 742 |
FAECES DISCOLOURED |
2 |
0.0001 |
| 743 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 744 |
HEART RATE INCREASED |
9 |
0.0001 |
| 745 |
STEVENS-JOHNSON SYNDROME |
2 |
0.0001 |
| 746 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
| 747 |
RASH PAPULAR |
2 |
0.0001 |
| 748 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 749 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 750 |
HEART RATE IRREGULAR |
2 |
0.0001 |
| 751 |
MICTURITION URGENCY |
1 |
0.0001 |
| 752 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 753 |
CARDIAC FAILURE |
7 |
0.0001 |
| 754 |
METASTASES TO LUNG |
1 |
0.0001 |
| 755 |
PERICARDIAL EFFUSION |
2 |
0.0001 |
| 756 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 757 |
CAESAREAN SECTION |
1 |
0.0001 |
| 758 |
HYPERKALAEMIA |
3 |
0.0001 |
| 759 |
COMPLETED SUICIDE |
7 |
0.0001 |
| 760 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 761 |
RASH ERYTHEMATOUS |
4 |
0.0001 |
| 762 |
HYPOGLYCAEMIA |
4 |
0.0001 |
| 763 |
LIVER INJURY |
2 |
0.0001 |
| 764 |
CARDIOMEGALY |
1 |
0.0001 |
| 765 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 766 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 767 |
LEUKOPENIA |
4 |
0.0001 |
| 768 |
MUSCULOSKELETAL STIFFNESS |
7 |
0.0001 |
| 769 |
POISONING |
1 |
0.0001 |
| 770 |
UNEVALUABLE EVENT |
6 |
0.0001 |
| 771 |
MYDRIASIS |
1 |
0.0001 |
| 772 |
HAEMOGLOBIN DECREASED |
8 |
0.0001 |
| 773 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 774 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 775 |
HIATUS HERNIA |
1 |
0.0001 |
| 776 |
HAEMATOMA |
2 |
0.0001 |
| 777 |
MUCOSAL INFLAMMATION |
2 |
0.0001 |
| 778 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
2 |
0.0001 |
| 779 |
PANCREATITIS |
4 |
0.0001 |
| 780 |
ASPARTATE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 781 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 782 |
OEDEMA |
4 |
0.0001 |
| 783 |
DYSPHAGIA |
7 |
0.0001 |
| 784 |
PULMONARY EMBOLISM |
7 |
0.0001 |
| 785 |
SKIN LESION |
2 |
0.0001 |
| 786 |
PROCEDURAL PAIN |
2 |
0.0001 |
| 787 |
BLISTER |
4 |
0.0001 |
| 788 |
RENAL FAILURE ACUTE |
3 |
0.0001 |
| 789 |
DIALYSIS |
1 |
0.0001 |
| 790 |
BRONCHOSPASM |
1 |
0.0001 |
| 791 |
PARALYSIS |
1 |
0.0001 |
| 792 |
HYPERSOMNIA |
2 |
0.0001 |
| 793 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 794 |
PULMONARY ARTERIAL HYPERTENSION |
1 |
0.0001 |
| 795 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 796 |
GASTROENTERITIS |
1 |
0.0001 |
| 797 |
ANGIOEDEMA |
3 |
0.0001 |
| 798 |
DRUG WITHDRAWAL SYNDROME NEONATAL |
1 |
0.0001 |
| 799 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 800 |
THERAPY NON-RESPONDER |
3 |
0.0001 |
| 801 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 802 |
DISCOMFORT |
4 |
0.0001 |
| 803 |
ALANINE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 804 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 805 |
HYPERSENSITIVITY |
12 |
0.0001 |
| 806 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 807 |
VOMITING |
30 |
0.0001 |
| 808 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 809 |
OBESITY |
1 |
0.0001 |
| 810 |
CONDITION AGGRAVATED |
19 |
0.0001 |
| 811 |
INTENTIONAL OVERDOSE |
4 |
0.0001 |
| 812 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 813 |
MOVEMENT DISORDER |
2 |
0.0001 |
| 814 |
INFECTION |
9 |
0.0001 |
| 815 |
DEEP VEIN THROMBOSIS |
4 |
0.0001 |
| 816 |
METASTASES TO BONE |
1 |
0.0001 |
| 817 |
INFUSION RELATED REACTION |
4 |
0.0001 |
| 818 |
CYTOMEGALOVIRUS INFECTION |
1 |
0.0001 |
| 819 |
FUNGAL INFECTION |
2 |
0.0001 |
| 820 |
URINARY RETENTION |
2 |
0.0001 |
| 821 |
CONSTIPATION |
13 |
0.0001 |
| 822 |
FACE OEDEMA |
1 |
0.0001 |
| 823 |
CANDIDA INFECTION |
1 |
0.0001 |
| 824 |
HEPATIC ENZYME INCREASED |
4 |
0.0001 |
| 825 |
HAEMATURIA |
2 |
0.0001 |
| 826 |
DYSPNOEA |
33 |
0.0001 |
| 827 |
NEOPLASM PROGRESSION |
2 |
0.0001 |
| 828 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 829 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 830 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 831 |
DRUG ERUPTION |
1 |
0.0001 |
| 832 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 833 |
NO ADVERSE EVENT |
10 |
0.0001 |
| 834 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
2 |
0.0001 |
| 835 |
PELVIC PAIN |
1 |
0.0001 |
| 836 |
CRYING |
2 |
0.0001 |
| 837 |
TREMOR |
9 |
0.0001 |
| 838 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 839 |
PANCYTOPENIA |
3 |
0.0001 |
| 840 |
THROMBOCYTOPENIA |
6 |
0.0001 |
| 841 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 842 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 843 |
HYPONATRAEMIA |
3 |
0.0001 |
| 844 |
CEREBROVASCULAR ACCIDENT |
9 |
0.0001 |
| 845 |
HALLUCINATION |
4 |
0.0001 |
| 846 |
CONVULSION |
3 |
0.0001 |
| 847 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 848 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 849 |
GENERAL PHYSICAL HEALTH DETERIORATION |
6 |
0.0001 |
| 850 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 851 |
ORAL HERPES |
1 |
0.0001 |
| 852 |
SINUS DISORDER |
1 |
0.0001 |
| 853 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 854 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 855 |
CONFUSIONAL STATE |
8 |
0.0000 |
| 856 |
STOMATITIS |
3 |
0.0000 |
| 857 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 858 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 859 |
RIB FRACTURE |
1 |
0.0000 |
| 860 |
PERITONITIS |
1 |
0.0000 |
| 861 |
TREATMENT FAILURE |
4 |
0.0000 |
| 862 |
EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 863 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 864 |
HAEMORRHAGE |
5 |
0.0000 |
| 865 |
URTICARIA |
8 |
0.0000 |
| 866 |
DERMATITIS |
1 |
0.0000 |
| 867 |
EATING DISORDER |
1 |
0.0000 |
| 868 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 869 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 870 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 871 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 872 |
DRUG INEFFECTIVE |
59 |
0.0000 |
| 873 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 874 |
SLEEP DISORDER |
3 |
0.0000 |
| 875 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 876 |
PRESYNCOPE |
1 |
0.0000 |
| 877 |
UNDERDOSE |
3 |
0.0000 |
| 878 |
ABASIA |
1 |
0.0000 |
| 879 |
THERAPY CESSATION |
2 |
0.0000 |
| 880 |
DRUG RESISTANCE |
1 |
0.0000 |
| 881 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 882 |
ABDOMINAL DISTENSION |
4 |
0.0000 |
| 883 |
FEAR |
1 |
0.0000 |
| 884 |
JAUNDICE |
1 |
0.0000 |
| 885 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 886 |
DEVICE DELIVERY SYSTEM ISSUE |
1 |
0.0000 |
| 887 |
MEDICATION ERROR |
2 |
0.0000 |
| 888 |
HAEMOPTYSIS |
1 |
0.0000 |
| 889 |
HERPES ZOSTER |
2 |
0.0000 |
| 890 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 891 |
ASCITES |
1 |
0.0000 |
| 892 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 893 |
HEPATIC FAILURE |
1 |
0.0000 |
| 894 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 895 |
OEDEMA PERIPHERAL |
4 |
0.0000 |
| 896 |
VERTIGO |
2 |
0.0000 |
| 897 |
BLOOD PRESSURE INCREASED |
5 |
0.0000 |
| 898 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 899 |
FEMUR FRACTURE |
1 |
0.0000 |
| 900 |
HEAD INJURY |
1 |
0.0000 |
| 901 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 902 |
DRUG DEPENDENCE |
5 |
0.0000 |
| 903 |
RHINORRHOEA |
2 |
0.0000 |
| 904 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 905 |
AMNESIA |
2 |
0.0000 |
| 906 |
EYE DISORDER |
1 |
0.0000 |
| 907 |
NAUSEA |
24 |
0.0000 |
| 908 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 909 |
DEHYDRATION |
4 |
0.0000 |
| 910 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 911 |
MALIGNANT NEOPLASM PROGRESSION |
3 |
0.0000 |
| 912 |
ERYTHEMA |
6 |
0.0000 |
| 913 |
INJURY |
2 |
0.0000 |
| 914 |
ANXIETY |
8 |
0.0000 |
| 915 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
0.0000 |
| 916 |
RASH |
12 |
0.0000 |
| 917 |
EPISTAXIS |
2 |
0.0000 |
| 918 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 919 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 920 |
PALPITATIONS |
3 |
0.0000 |
| 921 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 922 |
THROMBOSIS |
2 |
0.0000 |
| 923 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 924 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 925 |
HYPERHIDROSIS |
3 |
0.0000 |
| 926 |
DIARRHOEA |
15 |
0.0000 |
| 927 |
DEATH |
20 |
0.0000 |
| 928 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 929 |
MENTAL DISORDER |
1 |
0.0000 |
| 930 |
COVID-19 |
4 |
0.0000 |
| 931 |
PAIN |
14 |
0.0000 |
| 932 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 933 |
NEUTROPENIA |
3 |
0.0000 |
| 934 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 935 |
RENAL DISORDER |
1 |
0.0000 |
| 936 |
SWELLING |
2 |
0.0000 |
| 937 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 938 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 939 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 940 |
FLUSHING |
2 |
0.0000 |
| 941 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 942 |
SPEECH DISORDER |
1 |
0.0000 |
| 943 |
DEPRESSED MOOD |
1 |
0.0000 |
| 944 |
RASH PRURITIC |
1 |
0.0000 |
| 945 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 946 |
INFLUENZA |
2 |
0.0000 |
| 947 |
COUGH |
5 |
0.0000 |
| 948 |
ASTHMA |
2 |
0.0000 |
| 949 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 950 |
BONE PAIN |
1 |
0.0000 |
| 951 |
CHILLS |
2 |
0.0000 |
| 952 |
FEELING ABNORMAL |
4 |
0.0000 |
| 953 |
JOINT SWELLING |
2 |
0.0000 |
| 954 |
MUSCLE SPASMS |
3 |
0.0000 |
| 955 |
CHEST PAIN |
3 |
0.0000 |
| 956 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 957 |
INSOMNIA |
4 |
0.0000 |
| 958 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 959 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 960 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 961 |
MOBILITY DECREASED |
1 |
0.0000 |
| 962 |
HYPOAESTHESIA |
2 |
0.0000 |
| 963 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 964 |
PRURITUS |
5 |
0.0000 |
| 965 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 966 |
DRY MOUTH |
1 |
0.0000 |
| 967 |
DIZZINESS |
6 |
0.0000 |
| 968 |
DRUG ABUSE |
1 |
0.0000 |
| 969 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 970 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 971 |
DEVICE ISSUE |
1 |
0.0000 |
| 972 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 973 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 974 |
CONTUSION |
1 |
0.0000 |
| 975 |
FATIGUE |
8 |
0.0000 |
| 976 |
SINUSITIS |
1 |
0.0000 |
| 977 |
FALL |
3 |
0.0000 |
| 978 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 979 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 980 |
ASTHENIA |
3 |
0.0000 |
| 981 |
HEADACHE |
5 |
0.0000 |
| 982 |
DRY SKIN |
1 |
0.0000 |
| 983 |
PARAESTHESIA |
1 |
0.0000 |
| 984 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 985 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 986 |
DEPRESSION |
1 |
0.0000 |
| 987 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 988 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 989 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 990 |
ARTHRALGIA |
1 |
0.0000 |
| 991 |
MALAISE |
1 |
0.0000 |